🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Xanamem® is being developed as a potential treatment for symptomatic, early...
Status
Active Not Recruiting
Location
ACW Investigative Site 218
Start Date
2024-04-12
Trial ID
NCT06125951
Xanamem™ is being developed as a potential drug for Alzheimer's disease. Th...
Status
Completed
Location
Linear Clinical Research
Start Date
2019-01-21
Trial ID
NCT03830762
Treatments Being Tested
The purpose of this study is to determine whether the drug UE2343, a potent...
Status
Completed
Location
Linear Clinical Research
Start Date
2015-02
Trial ID
NCT02616445
A randomised, double-blind, placebo-controlled, phase I study in healthy su...
Status
Completed
Location
Simbec Research
Start Date
2013-01
Trial ID
NCT01770886
This XanADu Phase II study in mild Alzheimer's Disease (AD) is to assess th...
Status
Completed
Location
Tucson Neuroscience Research, LLC
Start Date
2017-03-23
Trial ID
NCT02727699
Treatments Being Tested
Xanamem is being developed as a potential treatment for symptomatic, early ...
Status
Completed
Location
Paratus Clinical Research Western Sydney
Start Date
2022-11-28
Trial ID
NCT05657691
Xanamem® is being developed as a potential drug for Mild Cognitive Impairme...
Status
Completed
Location
Paratus Clinical Research Canberra
Start Date
2021-06-30
Trial ID
NCT04983368
Treatments Being Tested